2013
DOI: 10.1055/s-0033-1347545
|View full text |Cite
|
Sign up to set email alerts
|

Einsatz von integrativen Heilmethoden durch postmenopausale Mammakarzinompatientinnen in der PreFace Phase IV Studie - eine prospektive, longitudinale Untersuchung

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…General information (including personal data, demographic data, disease, previous and current treatments, co-medication, social environment), IMed diary at the start of integrative therapy (month 0) and at the time points 3 (month 3), 6 (month 6), 9 (month 9) and 12 (month 12) (l " Table 1). Parts of the diary of the PreFace study (Evaluation of Predictive Factors regarding the Effectivity of Aromatase Inhibitor Therapy) were used as the basis when we developed our patient diary [43]. The PreFace study is a phase IV study where postmenopausal, hormone receptor-positive breast cancer patients are treated with the aromatase inhibitor letrozole [44].…”
Section: Integrative Medicine Patient Questionnaire and Diarymentioning
confidence: 99%
“…General information (including personal data, demographic data, disease, previous and current treatments, co-medication, social environment), IMed diary at the start of integrative therapy (month 0) and at the time points 3 (month 3), 6 (month 6), 9 (month 9) and 12 (month 12) (l " Table 1). Parts of the diary of the PreFace study (Evaluation of Predictive Factors regarding the Effectivity of Aromatase Inhibitor Therapy) were used as the basis when we developed our patient diary [43]. The PreFace study is a phase IV study where postmenopausal, hormone receptor-positive breast cancer patients are treated with the aromatase inhibitor letrozole [44].…”
Section: Integrative Medicine Patient Questionnaire and Diarymentioning
confidence: 99%